TAPT1-at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta.


Journal

EMBO molecular medicine
ISSN: 1757-4684
Titre abrégé: EMBO Mol Med
Pays: England
ID NLM: 101487380

Informations de publication

Date de publication:
10 07 2023
Historique:
revised: 16 05 2023
received: 17 02 2023
accepted: 25 05 2023
medline: 11 7 2023
pubmed: 9 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

Osteogenesis imperfecta (OI) is a hereditary skeletal disorder primarily affecting collagen type I structure and function, causing bone fragility and occasionally versatile extraskeletal symptoms. This study expands the spectrum of OI-causing TAPT1 mutations and links extracellular matrix changes to signaling regulation.

Identifiants

pubmed: 37292039
doi: 10.15252/emmm.202317528
pmc: PMC10331569
doi:

Substances chimiques

Collagen Type I 0

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17528

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/T001984/1
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Bone Res. 2021 Nov 10;9(1):48
pubmed: 34759273
Cilia. 2017 May 25;6:8
pubmed: 28560031
Bone. 2009 Jun;44(6):1063-8
pubmed: 19254787
J Bone Miner Res. 2004 Nov;19(11):1873-81
pubmed: 15476588
J Spine Surg. 2017 Dec;3(4):666-678
pubmed: 29354746
J Biol Chem. 2006 Nov 24;281(47):35598-602
pubmed: 17035233
EMBO Mol Med. 2023 Jul 10;15(7):e17528
pubmed: 37292039
J Clin Invest. 2017 Jun 30;127(7):2539-2540
pubmed: 28628035
iScience. 2021 Jun 17;24(7):102739
pubmed: 34278253
Bone. 2021 Feb;143:115754
pubmed: 33189914
J Nanobiotechnology. 2022 Oct 29;20(1):462
pubmed: 36309688
Mol Endocrinol. 2004 May;18(5):1222-37
pubmed: 14976225
EMBO Mol Med. 2023 Feb 8;15(2):e16478
pubmed: 36652330
Am J Hum Genet. 2015 Oct 1;97(4):521-34
pubmed: 26365339
Hum Genet. 2023 Mar;142(3):457-476
pubmed: 36697720
Am J Med Genet A. 2019 Jun;179(6):908-914
pubmed: 30896082
Am J Hum Genet. 2013 Apr 4;92(4):590-7
pubmed: 23499310

Auteurs

Julia Etich (J)

Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Department of Orthopedics (Friedrichsheim), University Hospital Frankfurt, Goethe University Frankfurt/Main, Frankfurt, Germany.
Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Oliver Semler (O)

Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Family Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Nicola L Stevenson (NL)

Cell Biology Laboratories, School of Biochemistry, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, UK.

Alice Stephan (A)

Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Department of Orthopedics (Friedrichsheim), University Hospital Frankfurt, Goethe University Frankfurt/Main, Frankfurt, Germany.
Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Roberta Besio (R)

Biochemistry Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Nadia Garibaldi (N)

Biochemistry Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Department of Biomedical Engineering, The City College of New York, New York, NY, USA.

Nadine Reintjes (N)

Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Claudia Dafinger (C)

Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Department II of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Max Christoph Liebau (MC)

Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Family Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Department II of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Molecular Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Ulrich Baumann (U)

Institute of Biochemistry, University of Cologne, Cologne, Germany.

Matthias Mörgelin (M)

Colzyx AB, Lund, Sweden.

Antonella Forlino (A)

Biochemistry Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy.

David J Stephens (DJ)

Cell Biology Laboratories, School of Biochemistry, Faculty of Life Sciences, University Walk, University of Bristol, Bristol, UK.

Christian Netzer (C)

Center for Rare Diseases, University Hospital Cologne, University of Cologne, Cologne, Germany.
Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Frank Zaucke (F)

Dr. Rolf M. Schwiete Research Unit for Osteoarthritis, Department of Orthopedics (Friedrichsheim), University Hospital Frankfurt, Goethe University Frankfurt/Main, Frankfurt, Germany.

Mirko Rehberg (M)

Department of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Family Health, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH